Axovant Sciences Ltd. (AXON) |
|---|
| $10.69 52 Week Low | $24.24 2017-04-28 15:15:17 MDT | $23.58 52 Week High |
| Healthcare Sector | Biotechnology Industry |
| NYSE Stock Exchange | Bermuda Country |
| Market Cap: | $2,230,000,000 | Mid Cap (Between $2B and $10B) |
| Analyst Recommendation: | 1.9 | Analysts say: Buy. (1=Strong Buy, 5=Strong Sell) |
| Beta: | N/A | Unknown Beta. A beta of 1 means that stock will go up or down at the same rate as the S&P 500 index. |
ForwardPE: Unknown | 5 Yr Est Growth: Unknown | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: 50.37% | % Above 200 DayMA: 76.81% |
AXON Performance 52 Weeks: 56.77% | S&P 500 Performance 52 Weeks: 12.50% |
Uptrend is still intact: AXON is above both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week High than 52 Week Low. | AXON outperforming S&P 500 by 44.27% the last 52 Weeks. AXON is close to 52 week high. |
Price To Book: 12.83 | Not so great value. Low Price to Book means better value. A P/B value of 5 or less is great. But consider other metrics and maybe the growth and yield makes it worth it. |
EV to EBITDA: -12.25 | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | N/A | 17.28% | Unknown. |
| % Held By Institutions | N/A | 62.07% | Unknown. |
| Short % Of Float | 20.47% | 07.02% | Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards. |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | N/A | -05.28% | Unknown. |
| Return on Equity % | N/A | -08.79% | Unknown. |
| Return on Assets % | N/A | -01.29% | Unknown. |
| Revenue Per Employee | $N/A | $883,096.70 | Unknown. |
| Price to Cash | 12.00 | 5.52 | Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|